Verona Pharma (NASDAQ:VRNA) Given New $36.00 Price Target at HC Wainwright
Verona Pharma (NASDAQ:VRNA – Get Free Report) had its price target boosted by equities researchers at HC Wainwright from $32.00 to $36.00 in a research note issued to investors on Thursday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. HC Wainwright’s target price points to a potential upside of 148.96% from […]
More Stories
PlayDapp Trading 2.7% Lower Over Last Week (PLA)
PlayDapp (PLA) traded down 7.3% against the U.S. dollar during the one day period ending at 16:00 PM ET on...
iExec RLC Hits 24 Hour Trading Volume of $8.48 Million (RLC)
iExec RLC (RLC) traded 7.8% lower against the U.S. dollar during the one day period ending at 16:00 PM Eastern...
NULS Reaches Self Reported Market Cap of $30.12 Million (NULS)
NULS (NULS) traded 6.1% lower against the dollar during the 1 day period ending at 16:00 PM E.T. on July...
BABB (BAX) Market Capitalization Reaches $6.43 Million
BABB (BAX) traded down 3.8% against the US dollar during the 1-day period ending at 16:00 PM Eastern on July...
Coinmetro Token Reaches Self Reported Market Capitalization of $194.45 Million (XCM)
Coinmetro Token (XCM) traded up 2.6% against the U.S. dollar during the one day period ending at 16:00 PM Eastern...
First Industrial Realty Trust, Inc. (NYSE:FR) Shares Purchased by Retirement Systems of Alabama
Retirement Systems of Alabama boosted its holdings in shares of First Industrial Realty Trust, Inc. (NYSE:FR – Free Report) by...